Showing results (21-30 of 71) with videos related to
Sort By:
Pageof 8
Journal of Infection in Developing Countries|January 2, 2013
Characterization of Citrobacter sp. line 328 as a source of Vi for a Vi-CRM(197) glycoconjugate vaccine against Salmonella TyphiSimona Rondini, Francesca Micoli, Luisa Lanzilao, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2008
Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteersMaria Cecilia Huaman, Laura B Martin, Elissa Malkin, et al.Vaccine|July 13, 2024
Vaccine value profile for invasive non-typhoidal Salmonella diseaseLaura B Martin, Bieke Tack, Christian S Marchello, et al.Protein Expression and Purification|August 4, 2006
Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tagRichard L Shimp, Laura B Martin, Yanling Zhang, et al.Infection and Immunity|July 25, 2006
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activitySanjay Singh, Kazutoyo Miura, Hong Zhou, et al.Vaccine|March 29, 2011
Long term stability of a recombinant Plasmodium falciparum AMA1 malaria vaccine adjuvanted with Montanide(®) ISA 720 and stabilized with glycineDaming Zhu, Holly McClellan, Weili Dai, et al.Plos Neglected Tropical Diseases|October 13, 2021
Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypesFrancesco Citiulo, Francesca Necchi, Francesca Mancini, et al.Plos One|August 7, 2015
Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHBChristiane Gerke, Anna Maria Colucci, Carlo Giannelli, et al.Current Topics in Microbiology and Immunology|May 26, 2022
Shigella-Controlled Human Infection Models: Current and Future PerspectivesKristen A Clarkson, Chad K Porter, Kawsar R Talaat, et al.Frontiers in Cellular and Infection Microbiology|February 21, 2022
Dissecting <i>in Vitro</i> the Activation of Human Immune Response Induced by <i>Shigella sonnei</i> GMMASerena Tondi, Bruna Clemente, Carmen Esposito, et al.Pageof 8